Key result
Perphenazine titration to twice daily resulted in a 41% reduction in PANSS score and complete resolution of Cotard's syndrome in a patient with treatment-resistant schizophrenia.
Why the study?
Antipsychotic choice varies widely based on symptomatology, prior response, and adverse reactions, motivating evaluation of perphenazine in treatment-resistant disease.
Does perphenazine improve symptoms in a patient with treatment-resistant schizophrenia?
Case Report (n=1)
Does perphenazine improve symptoms in a patient with treatment-resistant schizophrenia?
Perphenazine may be a cost-effective and well-tolerated alternative for patients with treatment-resistant schizophrenia who cannot adhere to clozapine monitoring.
Answers are grounded in this paper and cite their sources.
May guide sequential trials in refractory schizophrenia; leaves open mechanisms of antipsychotic resistance.
Antipsychotics are considered a gold standard treatment for schizophrenia. However, there is considerable variation in antipsychotic medication choice. Factors considered involved include symptomatology, prior response, and adverse reactions. This case report presents a 38-year-old male patient with schizophrenia in acute psychosis refractory to several antipsychotics. Hypotheses for the mechanism of action of antipsychotics and psychopharmacology are discussed, and treatment resistance is defined. The patient's psychiatric, medical, and social history and past antipsychotic medications are reviewed. Afterward, the rationale for initiating perphenazine is discussed, and the patient's improvement with this medication is examined. Current literature on perphenazine's efficacy is also reviewed and discussed alongside its limitations.
No takes yet. Share an insight, caveat, or question.
Hower et al. (2024) conducted a case report in Treatment-Resistant Schizophrenia (n=1). Perphenazine was evaluated on Positive and Negative Syndrome Scale (PANSS) score. Perphenazine titration to twice daily resulted in a 41% reduction in PANSS score and complete resolution of Cotard's syndrome in a patient with treatment-resistant schizophrenia.
Synapse has enriched 10 related papers. Consider them for comparative context: